This podcast episode is an interview with Dr. Christopher Jones, the Acting Director of the U.S. Centers for Disease Control & Prevention’s Injury Center, about CDC’s new draft clinical practice guideline (CPG) for prescribing opioids and what it means for current practice. Dr. Jones walks listeners through changes to the CPG from the 2016 version, the process for revising the CPG, and the types of input from members that will best assist CDC as they finalize the CPG.
SPEAKERS
Dr. Christopher Jones currently serves as the acting director of the National Center for Injury Prevention and Control at CDC. In this role, he oversees all aspects of the Injury Center, including providing scientific leadership and overseeing the Center’s strategic priorities of preventing drug overdose, suicide, and adverse childhood experiences. Dr. Jones has previously served in leadership roles at HHS, SAMHSA, and FDA, and has authored more than 100 peer-reviewed scientific papers.
Jillanne Schulte Wall is the senior director of Health & Regulatory Policy for the American Society of Health-System Pharmacists (ASHP) in Bethesda, MD. She serves as ASHP’s primary liaison to federal regulatory agencies and, in conjunction with other members of the Government Relations team, develops and communicates of ASHP’s positions on federal and state laws, regulations, and guidance related to the profession of pharmacy. Additionally, Jillanne works closely with stakeholders in pharmacy, medicine, manufacturing, and patient advocacy on legislative and regulatory issues of importance to ASHP members.